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Abstract
Background: Fournier’s gangrene is a rare necrotizing soft tissue infection of the scrotum and penis. We report, to
our knowledge, the first case of Fournier’s gangrene caused by Streptococcus dysgalactiae subsp. equisimilis (SDSE), a
strain of pyogenic β-hemolytic streptococci that is increasingly being recognized as an important human pathogen.
Case presentation: We describe a healthy 59 year-old Caucasian male who presented to the emergency
department with Fournier’s gangrene of the penis and scrotum, with extension to the anterior abdominal wall. He
underwent urgent surgical debridement of his scrotum, penis, and anterior abdomen. Swabs from the scrotum
grew Gram-positive cocci, which were initially identified as Streptococcus anginosus group by matrix-assisted laser
desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). However, polymerase chain reaction (PCR)
amplification and sequencing of the 16S rRNA gene identified the isolate as Streptococcus dysgalatiae subspecies
equisimilis (SDSE). The incidences of invasive S. anginosus group and SDSE infections at the London Health Sciences
Centre, a tertiary-care institution in southwestern Ontario, were determined between August 1, 2011 and August 31,
2012, revealing a slightly lower rate of SDSE (3.2 cases per 100,000 population) than other studies.
Conclusions: This case highlights a unique disease manifestation of the emerging human pathogen Streptococcus
dysgalatiae subspecies equisimilis that has not been previously reported. This case also underscores the limitations
of MALDI-TOF MS in differentiating between closely-related streptococcal species which may have different
pathogenic profiles.
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Background
Fournier’s gangrene is a rare necrotizing infection of the
male genitalia [1,2]. It is classically characterized by in-
tense pain and tenderness in the genitals, rapidly
progressing to gangrene and septic shock. Risk factors
include diabetes [1], immune compromise, drug use,
obesity, and trauma to the perineum [2,3]. Most cases of
Fournier’s gangrene are polymicrobial [2], and com-
monly isolated microorganisms include Escherichia,
Klebsiella, Bacteroides, Clostridium, streptococci and en-
terococci [1]. Early therapy is critical, including surgi-
cal debridement, broad-spectrum antibiotics, and skin
grafting [1-3]. We describe a case of Fournier’s gangrene
in a healthy male caused by Streptococcus dysgalactiae
subsp. equisimilis (SDSE), initially misidentified as Strepto-
coccus anginosus group. SDSE is a pyogenic β-hemolytic
Streptococcus that is emerging as a human pathogen with
a similar disease profile to S. pyogenes [4-6]. While it pri-
marily presents as skin and soft-tissue infections, including
cellulitis and necrotizing fasciitis [4], SDSE can also cause
endocarditis, rheumatic fever, and streptococcal toxic
shock-like syndrome [5,6]. With an ever-increasing clinical
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burden, there is a need to accurately identify invasive
SDSE infections.
Case presentation
A 59 year-old, previously healthy Caucasian male presen-
ted with scrotal and penile pain for six days, and brownish-
black discoloration of the scrotum. His past medical and
surgical history was non-contributory and he did not take
any medications. There was no history of trauma or sepsis
in the genital area, and there were no symptoms of dysuria
or hematuria. A review of systems was unremarkable. On
examination, the patient was alert and oriented, but
appeared unwell. He was also febrile (38.3°C), tachycardic
(heart rate 116/min), and normotensive (blood pressure
136/79). His lower abdomen was erythematous with palp-
able subcutaneous emphysema extending to the umbilicus.
His penile shaft was swollen and tender, and his scrotum
was necrotic. Bloodwork revealed a white cell count of
17 × 109/L, hyponatremia (125 mmol/L), hypochloremia
(86 mmol/L), and elevated serum lactate (3.1 mmol/L).
The patient’s international normalized ratio (INR) was 1.6,
and his serum alanine-aminotransferase (ALT), and serum
aspartate-aminotransferase (AST) were elevated at 127 U/L,
and 66 U/L respectively. Blood glucose and serum creatinine
were within normal limits.
Intravenous treatment with vancomycin (1 g every 12 h),
and piperacillin-tazobactam (4.5 g every 8 h) was initiated.
The patient was urgently taken to the operating room and
underwent extensive debridement of his scrotum, penile
shaft, and anterior abdomen, while preserving the testes
and abdominal muscles. A small abscess cavity communi-
cating with the necrotizing infection was identified in the
right buttock and debrided. A suprapubic catheter was
placed for urinary diversion, and the patient was admitted to
the intensive care unit. After 48 hours, he underwent a
transverse colostomy to divert stool from his perineum, and
skin grafting to close his anterior abdominal wounds
and penile shaft. His testes were tunnelled into his thighs,
and after sixteen days in hospital, he was discharged home.
A swab from the scrotal tissue was taken during the initial
operation, and was streaked on blood agar plates, resulting
in a monoculture of uniformly-sized beta-haemolytic col-
onies. From this, the bacteria was isolated and subjected to
matrix-assisted laser desorption ionization–time of flight
mass spectrometry (MALDI-TOF MS) to identify the organ-
ism as Streptococcus anginosus group (score = 2.3), although
the software (Biotyper software version 3.0) was unable to
distinguish the species. Susceptibility testing was performed
by the Kirby-Bauer disc diffusion method [7], and the organ-
ism was sensitive to ceftriaxone, clindamycin, erythromycin,
penicillin, and vancomycin. Polymerase chain reaction
(PCR) amplification (Table 1) and sequencing of the 16S
rRNA amplicon from DNA isolated from overnight cultures
of two isolated colonies identified the isolate as Streptococcus
dysgalatiae subspecies equisimilis. This was further con-
firmed by sequencing the emm amplicon and performing a
BLAST search on the Centers for Disease Control (CDC)
streptococcal emm sequence database [8]: the isolate was
identified as group G Streptococcus emm type stG643.0. Fur-
ther PCR amplification experiments (Additional file 1:
Figure S1) did not detect any of the 11 known streptococcal
superantigen genes [9], when compared to genomic DNA
preparations of S. pyogenes serotypes MGAS5005 [9], SF370
[10], MGAS8232 [10], and MGAS315 [10], which served as
positive controls. In addition, proliferation assays [11] con-
firmed the absence of Group A streptococcal superantigen
activity in the isolate (Addition file 1: Figure S2). Briefly,
supernatants from overnight cultures of the isolate were
added to fresh, gradient-purified human peripheral blood
Table 1 List of primers used to amplify streptococcal
superantigen genes, 16S ribosomal RNA (rRNA),
and emm genes
Name Sequence 5′-3′ Source
SpeA forward AAAGTTGCCATCTCTTGGTTC Sigma genosys
SpeA reverse CAAGAGGTATTTGCTCAACAAGAC Sigma genosys
SpeC forward TTTGAGCAGGCGTAATTCCT Sigma genosys
SpeC reverse TTCAACGACACACACATTAAACA Sigma genosys
SpeG forward ACCCCATGCGATTATGAAAA Sigma genosys
SpeG reverse GGGAGACCAAAAACATCGAC Sigma genosys
SpeH forward ATTCCAATGTTGTTCAAGCAAA Sigma genosys
SpeH reverse TGAGCGGTTACTTTCGGTTT Sigma genosys
SpeI forward TCCGCCATTTTCAGGTAGTT Sigma genosys
SpeI reverse TTTCCTTCCTCAAAGCCAGA Sigma genosys
SpeJ forward GCTCTCGACCTCAGAATCAA Sigma genosys
SpeJ reverse CTTTCATGGGTACGGAAGTG Sigma genosys
SpeK forward CAAACAAGGAACGCAATTGAT Sigma genosys
SpeK reverse GTGTCTAATGCCACCGTCT Sigma genosys
SpeL forward ATAAGTCAGCACCTTCCTCTTTC Sigma genosys
SpeL reverse AAATCTCCCGTTACCTTCCA Sigma genosys
SpeM forward AACTTCTTCTTCCTTAAAGCGTCT Sigma genosys
SpeM reverse TGCTGTGTTGGTTAATAGCGA Sigma genosys
SmeZ forward TTTCTCGTCCTGTGATTGGA Sigma genosys
SmeZ reverse AATGGGACGGAGAACATAGC Sigma genosys
SSA forward ACAGGTCAGCTTTTACAGCA Sigma genosys
SSA reverse GGGCATCATATCGTACCAAA Sigma genosys
16S rRNA forward AGAGTTTGATCCTGGCTCAG Invitrogen life
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mononuclear cells (PBMCs; 2.0 × 105 cells/well) in 96-well
plates. After 3 days, 3H-thymidine was added for 18 h to
measure proliferation. Supernatant from S. pyogenes strain
MGAS5005 [9] served as a positive control.
We also used the London Health Sciences Centre
(LHSC) microbiology database to retrospectively review
patients with invasive S. anginosus group or SDSE infec-
tions at LHSC (a tertiary-care centre in Southwestern
Ontario that serves a regional population of 435 000) be-
tween August 1, 2011 and August 31, 2012. The review
was conducted according to the Helsinki Declaration,
and approved by the Research Ethics Board of Western
University (approval number 103036). Incidences were
calculated using Statistics Canada census data from 2011
[12]. We identified 17 cases of invasive S. anginosus
group infections (3.9 cases per 100,000 population), and
14 cases of invasive SDSE infections (3.2 cases per
100,000 population; Table 2). When testing antibiotic
susceptibility by the disc diffusion method [7], all SDSE
isolates were sensitive to penicillin, whereas 6% of S.
anginosus group isolates were resistant. Two SDSE iso-
lates (14%) were resistant to clindamycin and one (7%)
was resistant to erythromycin (Table 2).
Conclusions
Fournier’s gangrene was first identified in 1883, when
the French dermatologist and venereologist Jean Alfred
Fournier diagnosed a rapidly progressive gangrene of the
genitalia with no discernible etiology in five young men
[13]. Now defined as a necrotizing fasciitis of the peri-
neal or genital areas [1,2], Fournier’s gangrene remains
unusually rare, with an incidence ranging from 0.002%
to 0.005% of annual hospital admissions [14]. The infec-
tion can rapidly spread throughout the perineum, thighs,
and torso, subsequently leading to gangrene, septic
shock, and death if untreated. Although Group A
streptococci were thought to be the sole cause of
Fournier’s gangrene [15], subsequent clinical series have
emphasized the polymicrobial nature of the disease
[1,16], which is hypothesized to synergize enzyme pro-
duction and promote rapid multiplication and spread of
infection [1]. The most common causative microorgan-
isms include facultative organisms (E. coli, Klebsiella,
enterococci), along with anaerobes (Bacteroides, Fusoba-
cterium, Clostridium, or anaerobic or microaerophilic
Streptococci). This case is unique because the patient
lacked the typical risk factors associated with Fournier’s
gangrene, such as diabetes, immune compromise, obes-
ity, drug use, or genital trauma [1-3], and his infec-
tion was caused by Streptococcus dysgalactiae subsp.
equisimilis (SDSE).
SDSE, a pyogenic β-hemolytic streptococcus [17], usu-
ally colonizes the upper respiratory, gastrointestinal, and
female genital tracts [17]. However, it is increasingly be-
ing recognized as an important human pathogen [18],
with a wide spectrum of disease similar to that caused
by S. pyogenes [5], including endocarditis, rheumatic
fever, and streptococcal toxic shock-like syndrome [6].
In a recent population-based study, the burden of inva-
sive SDSE infections approximated that of invasive S.
pyogenes infections [4]. SDSE primarily presents as skin
and soft-tissue infections, including pyoderma, cellulitis,
wound infections, abscesses, erysipelas, and necrotizing
fasciitis [4]. SDSE contains either Lancefield group anti-
gens C or G, but needs to be distinguished from S.
anginosus group strains, which frequently contain the
same antigens. The use of MALDI-TOF MS to differen-
tiate between streptococcal species has been established
[19-21], although misidentification may occur because of
striking similarities in proteomic profiles [22,23]. The or-
ganism in our case was misidentified as S. anginosus
group by MALDI-TOF MS, because sequencing the 16S
rRNA segment confirmed the isolate as SDSE. While
few laboratories report identification of β-hemolytic
Group C and G streptococci to the species level [24],
differentiation should not be ignored because SDSE is
more invasive than the S. anginosus group [25], and may
have virulence factors similar to S. pyogenes [26,27]. Al-
though the presence of streptococcal superantigens such
as SpeG homologues have been described in SDSE
[6,28], our clinical isolate lacked Group A streptococcal
superantigen genes and activity. Nevertheless, our case
demonstrates the potential benefit of molecular assays in
differentiating closely-related streptococcal species, al-
though further studies are needed to assess their clinical
impact. To our knowledge, there are no other reports of
Fournier’s gangrene caused by Streptococcus dysgalactiae
subspecies equisimils (SDSE). One study isolated Group
C Streptococcus from the perineum of a diabetic male
Table 2 Characteristics of invasive SDSE and S. anginosus
group infections in a one-year period at London health
sciences centre
Characteristics SDSE S. anginosus group
Patients, n 14 17
Rate (per 100,000 population) 3.2 3.9
Source of organism, n (%)
Blood 11 (79) 6 (35)
Tissue 3 (21) 10 (59)
Cerebrospinal fluid (CSF) 0 (0) 1 (6)
Antibiotic resistance, n (%)
Penicillin 0 (0) 1 (6)
Ceftriaxone - 1 (6)
Erythromycin 1 (7) 2 (12)
Clindamycin 2 (14) 2 (12)
Vancomycin - 0 (0)
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with Fournier’s gangrene [29], but the species was not
reported, and a potential role for superantigens was not
investigated.
At our institution, the incidences of invasive S. anginosus
group and SDSE infections were 3.9 and 3.2 cases per
100,000 respectively (Table 2). The rate of invasive S.
anginosus group infection is slightly higher than previous
studies [4], while the rate of invasive SDSE infection is
slightly lower. Although rare penicillin-resistant SDSE
strains have been reported [30], isolates from our centre
were sensitive to penicillin. Six percent of S. anginosus
group isolates, however, were resistant to penicillin, which
is higher than other studies [31]. While the mechanisms of
resistance have yet to be fully elucidated, the potential
transfer of penicillin resistance determinants from related
Streptococcal species [32], together with selective antibiotic
pressure, may play a role in the emergence of penicillin re-
sistance in the S. anginosus group [4,33]. Therefore, the
addition of an aminoglycoside to a cell wall-active agent
may be appropriate for severe S. anginosus group infections
to avoid delayed response of infection [33]. Similar to other
studies [30] showing widespread resistance to macrolides
(16-24%) we also observed erythromycin resistance (12%
and 7% for S. anginosus group and SDSE isolates, respect-
ively), albeit at a lower rate. Additionally, 12% of S.
anginosus group isolates and 14% of SDSE isolates were re-
sistant to clindamycin, suggesting that despite the popular-
ity of macrolide and clindamycin use in infected patients,
they may not be appropriate for all cases.
In conclusion, we present a case of Fournier’s gan-
grene of the penis caused by SDSE, highlighting a
unique disease presentation of the organism, and under-
scoring the limitations of MALDI-TOF MS in differenti-
ating between closely-related streptococcal species
which may hixave differing pathogenic profiles.
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